We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Introducing an Advanced System for Real-Time Chemotaxis Research

By LabMedica International staff writers
Posted on 13 Oct 2010
A new high throughput solution for chemotaxis research has been created by combining an automated microplate cytometer with an advanced microconduit array system.

The advanced approach for living cell analysis comprises the TTP LabTech (Cambridge, United Kingdom) Acumen eX3 microplate cytometer and the BellBrooks Labs (Madison, WI, USA) "iuvo” Chemotaxis Assay Plate.

The Acumen eX3 performs cell-based screening using up to three lasers (at 405, 488, and 633 nm) and simultaneous four color detection for each laser to provide content-rich data. More...
This enables a wide range of fluorescent reagents to be combined in multicolor, multiplexed assays. Nonetheless, data file sizes are significantly smaller than those generated by high content imaging technologies are. With an achievable throughput of over 300,000 wells per day, the Acumen eX3 has become an enabling platform for many high content screening organizations.

The "iuvo” Chemotaxis Assay Plate is a high content, automation friendly microconduit array plate that facilitates horizontal chemotaxis in the presence of a defined gradient. Three-dimensional cell culture is easy to carry out, and the entire compartment is accessible to microscope-based instruments as well as plate scanners. The microchannel environment reduces dilution of secreted signaling molecules, and the media can be sampled for analysis of secreted factors.

Dr. Paul Wylie, Acumen product manager at TTP LabTech, said, "This has proved a successful combination of products for customers involved with chemotaxis as the Acumen eX3 and ”iuvo” plates offer an efficient alternative to the more traditional microscopy set-up requiring further off-line analysis. Setting up a good gradient often poses a challenge, but the "iuvo” plates eradicate this issue. The Acumen offers a fast and accurate analysis of the chemotaxis assay and whole well scanning enables multiple cell movements to be captured and analyzed within any one well.”

Related Links:
TTP LabTech
BellBrooks Labs




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.